1. Home
  2. BNR vs JUNE Comparison

BNR vs JUNE Comparison

Compare BNR & JUNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • JUNE
  • Stock Information
  • Founded
  • BNR 2014
  • JUNE 1998
  • Country
  • BNR China
  • JUNE Singapore
  • Employees
  • BNR N/A
  • JUNE N/A
  • Industry
  • BNR Medical Specialities
  • JUNE
  • Sector
  • BNR Health Care
  • JUNE
  • Exchange
  • BNR Nasdaq
  • JUNE Nasdaq
  • Market Cap
  • BNR 61.7M
  • JUNE 50.1M
  • IPO Year
  • BNR 2020
  • JUNE 2024
  • Fundamental
  • Price
  • BNR $5.66
  • JUNE $5.00
  • Analyst Decision
  • BNR
  • JUNE
  • Analyst Count
  • BNR 0
  • JUNE 0
  • Target Price
  • BNR N/A
  • JUNE N/A
  • AVG Volume (30 Days)
  • BNR 5.3K
  • JUNE 13.9K
  • Earning Date
  • BNR 03-27-2025
  • JUNE 11-07-2024
  • Dividend Yield
  • BNR N/A
  • JUNE N/A
  • EPS Growth
  • BNR N/A
  • JUNE N/A
  • EPS
  • BNR N/A
  • JUNE N/A
  • Revenue
  • BNR $72,832,704.00
  • JUNE $2,903,179.00
  • Revenue This Year
  • BNR $52.90
  • JUNE N/A
  • Revenue Next Year
  • BNR $48.35
  • JUNE N/A
  • P/E Ratio
  • BNR N/A
  • JUNE N/A
  • Revenue Growth
  • BNR N/A
  • JUNE N/A
  • 52 Week Low
  • BNR $0.57
  • JUNE $2.75
  • 52 Week High
  • BNR $8.99
  • JUNE $5.97
  • Technical
  • Relative Strength Index (RSI)
  • BNR 40.71
  • JUNE N/A
  • Support Level
  • BNR $4.41
  • JUNE N/A
  • Resistance Level
  • BNR $6.33
  • JUNE N/A
  • Average True Range (ATR)
  • BNR 0.54
  • JUNE 0.00
  • MACD
  • BNR -0.16
  • JUNE 0.00
  • Stochastic Oscillator
  • BNR 35.82
  • JUNE 0.00

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About JUNE Junee Limited Ordinary Shares

Junee Ltd is a holding company that operates through its subsidiary. It is engaged in providing design, fit-out, repair, and maintenance services for commercial and residential buildings. The design services include both the consultation with its staff and the actual design work. Fit-out works include installing protective materials to cover floors or walls, installing or constructing partition walls, installing switches, power outlets, telephone wiring, computer outlet covers, and other electrical and wiring works. Repair and maintenance works include, among other things, replacement of fixtures and fittings, repair and maintenance of cupboards and shelves, and repainting walls and ceilings. Geographically, the company derives all of its revenue from its customers in Hong Kong.

Share on Social Networks: